| Dr Guillermo Jose Ballarino, MD | |
|
24 Hospital Ave, Danbury, CT 06810-6099 | |
| (203) 739-7070 | |
| Not Available |
| Full Name | Dr Guillermo Jose Ballarino |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 21 Years |
| Location | 24 Hospital Ave, Danbury, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386810802 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 050532 (Connecticut) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 050532 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Danbury Hospital | Danbury, CT | Hospital |
| Putnam Hospital Center | Carmel, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nuvance Health Medical Practice Ct Inc | 4789597691 | 648 |
News Archive
Efforts to fast-track the approval of H1N1 (swine) flu vaccines will not compromise the safety or quality controls of vaccine production, the WHO said in a written statement Thursday, the Mail & Guardian reports.
Researchers have built a model to investigate the metastasis of cancer by examining the metabolism of breast epithelial cells and look at the role of signaling. This research, published in PLOS Computational Biology, may contribute to the development of cell specific anti-cancer interventions.
Qualitest Pharmaceuticals today confirmed that it has launched a generic version of Singulair (montelukast sodium) Tablets and Chewable Tablets, following the expiration of the last patent that provides Merck U.S. market exclusivity. Qualitest will begin shipping the product immediately. Montelukast Sodium Tablets are labeled for use in treating symptoms of asthma and allergic rhinitis.
Affymetrix, Inc.today announced that it has released an unparalleled data set based on extensive validation of novel SNPs from the 1000 Genomes Project. This data will give researchers access to more rare mutations for genome-wide association studies and will enable the rapid design of custom arrays for a variety of applications, including the validation of sequencing results.
A new test could predict which women have an aggressive form of breast cancer in the milk ducts (DCIS) and spare other women from unnecessary radiotherapy, according to research1 published in the British Journal of Cancer today.
› Verified 6 days ago
| Entity Name | Nuvance Health Medical Practice Ct Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407898117 PECOS PAC ID: 4789597691 Enrollment ID: O20031205000130 |
News Archive
Efforts to fast-track the approval of H1N1 (swine) flu vaccines will not compromise the safety or quality controls of vaccine production, the WHO said in a written statement Thursday, the Mail & Guardian reports.
Researchers have built a model to investigate the metastasis of cancer by examining the metabolism of breast epithelial cells and look at the role of signaling. This research, published in PLOS Computational Biology, may contribute to the development of cell specific anti-cancer interventions.
Qualitest Pharmaceuticals today confirmed that it has launched a generic version of Singulair (montelukast sodium) Tablets and Chewable Tablets, following the expiration of the last patent that provides Merck U.S. market exclusivity. Qualitest will begin shipping the product immediately. Montelukast Sodium Tablets are labeled for use in treating symptoms of asthma and allergic rhinitis.
Affymetrix, Inc.today announced that it has released an unparalleled data set based on extensive validation of novel SNPs from the 1000 Genomes Project. This data will give researchers access to more rare mutations for genome-wide association studies and will enable the rapid design of custom arrays for a variety of applications, including the validation of sequencing results.
A new test could predict which women have an aggressive form of breast cancer in the milk ducts (DCIS) and spare other women from unnecessary radiotherapy, according to research1 published in the British Journal of Cancer today.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Guillermo Jose Ballarino, MD 24 Hospital Ave, Danbury, CT 06810-6099 Ph: (203) 739-7070 | Dr Guillermo Jose Ballarino, MD 24 Hospital Ave, Danbury, CT 06810-6099 Ph: (203) 739-7070 |
News Archive
Efforts to fast-track the approval of H1N1 (swine) flu vaccines will not compromise the safety or quality controls of vaccine production, the WHO said in a written statement Thursday, the Mail & Guardian reports.
Researchers have built a model to investigate the metastasis of cancer by examining the metabolism of breast epithelial cells and look at the role of signaling. This research, published in PLOS Computational Biology, may contribute to the development of cell specific anti-cancer interventions.
Qualitest Pharmaceuticals today confirmed that it has launched a generic version of Singulair (montelukast sodium) Tablets and Chewable Tablets, following the expiration of the last patent that provides Merck U.S. market exclusivity. Qualitest will begin shipping the product immediately. Montelukast Sodium Tablets are labeled for use in treating symptoms of asthma and allergic rhinitis.
Affymetrix, Inc.today announced that it has released an unparalleled data set based on extensive validation of novel SNPs from the 1000 Genomes Project. This data will give researchers access to more rare mutations for genome-wide association studies and will enable the rapid design of custom arrays for a variety of applications, including the validation of sequencing results.
A new test could predict which women have an aggressive form of breast cancer in the milk ducts (DCIS) and spare other women from unnecessary radiotherapy, according to research1 published in the British Journal of Cancer today.
› Verified 6 days ago
Dr. Shivayogi V Magavi, MD Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 57 North St, Suite 103, Danbury, CT 06810 Phone: 203-744-7007 | |
Andrew Keller, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 27 Hospital Ave, Danbury, CT 06810 Phone: 203-797-7155 | |
Mary E. Blackman, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 79 Sand Pit Road, 102, Danbury, CT 06810 Phone: 203-749-5700 | |
Nirmalamma S Magavi, MD Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 57 North St, Suite 103, Danbury, CT 06810 Phone: 203-744-7007 | |
David D Weinshel, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-797-7173 | |
Dr. Michael Spiegel, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 33 Germantown Rd, 1st Floor, Danbury, CT 06810 Phone: 203-794-5600 Fax: 203-794-5611 | |
Michael Cohenuram, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 24 Hospital Ave, Danbury, CT 06810 Phone: 203-797-7742 Fax: 203-830-2090 |